Cargando…

The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategies

The treatment paradigms for head and neck squamous cell cancer (HNSCC) are changing due to the emergence of human papillomavirus-associated tumors (HPV-related), possessing distinct molecular profiles and responses to therapy. Retrospective studies have suggested that HPV-related HNSCCs are more fre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wierzbicka, Małgorzata, Szyfter, Krzysztof, Milecki, Piotr, Składowski, Krzysztof, Ramlau, Rodryg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2015
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631307/ https://www.ncbi.nlm.nih.gov/pubmed/26557780 http://dx.doi.org/10.5114/wo.2015.54389

Ejemplares similares

Comparison of Selected Immune and Hematological Parameters and Their Impact on Survival in Patients with HPV-Related and HPV-Unrelated Oropharyngeal Cancer
por: Brewczyński, Adam, et al.
Publicado: (2021)

Variable course of progression of oral cavity and oropharyngeal carcinoma in young adults
por: Pabiszczak, Maciej Szczepan, et al.
Publicado: (2013)

Circulating HPV16 DNA may complement imaging assessment of early treatment efficacy in patients with HPV-positive oropharyngeal cancer
por: Rutkowski, Tomasz W., et al.
Publicado: (2020)

Analysis of Selected Nutritional Parameters in Patients with HPV-Related and Non-HPV-Related Oropharyngeal Cancer before and after Radiotherapy Alone or Combined with Chemotherapy
por: Brewczyński, Adam, et al.
Publicado: (2022)

Treatment de-escalation for HPV-driven oropharyngeal cancer: Where do we stand?
por: Mirghani, Haitham, et al.
Publicado: (2017)

Determinants of the level of circulating-tumor HPV16 DNA in patients with HPV-associated oropharyngeal cancer at the time of diagnosis
por: Kentnowski, Marek, et al.
Publicado: (2023)

What is the future of treatment de-escalation for HPV-positive oropharyngeal cancer? A review of ongoing clinical trials
por: Mensour, Emma A., et al.
Publicado: (2022)

Targeted Therapy as a Potential De-Escalation Strategy in Locally Advanced HPV-Associated Oropharyngeal Cancer: A Literature Review
por: Chitsike, Lennox, et al.
Publicado: (2021)

Stensen's duct injuries: the role of sialendoscopy and adjuvant botulinum toxin injection
por: Kopeć, Tomasz, et al.
Publicado: (2013)

Erlotinib in salvage treatment of patients with advanced non-small cell lung cancer: results of an expanded access programme in Poland
por: Kowalski, Dariusz M., et al.
Publicado: (2012)

Current views on molecularly targeted therapy for lung cancer – a review of literature from the last five years
por: Rybarczyk-Kasiuchnicz, Agnieszka, et al.
Publicado: (2018)

Prognostic factors in oral and oropharyngeal cancer based on ultrastructural analysis and DNA methylation of the tumor and surgical margin
por: Mielcarek-Kuchta, Daniela, et al.
Publicado: (2014)

Detection of HPV related oropharyngeal cancer in oral rinse specimens
por: Rosenthal, Matthew, et al.
Publicado: (2017)

De-escalated radiation for human papillomavirus virus-related oropharyngeal cancer: evolving paradigms and future strategies
por: Chen, Allen M.
Publicado: (2023)

Immunotherapy in HPV-Related Oropharyngeal Cancers
por: Roof, Logan, et al.
Publicado: (2023)

Algorithm changes in treatment of submandibular gland sialolithiasis
por: Kopeć, Tomasz, et al.
Publicado: (2013)

Anti-angiogenic agents in the treatment of non-small cell lung cancer
por: Szyszka-Barth, Katarzyna, et al.
Publicado: (2014)

Nutritional Support in Head and Neck Radiotherapy Patients Considering HPV Status
por: Brewczyński, Adam, et al.
Publicado: (2020)

Deintensification Strategies Using Proton Beam Therapy for HPV-Related Oropharyngeal Cancer
por: Gamez, Mauricio E., et al.
Publicado: (2021)

Current Evidence of a Deintensification Strategy for Patients with HPV-Related Oropharyngeal Cancer
por: Sung, Soo-Yoon, et al.
Publicado: (2022)

Adjuvant Radiation Therapy Alone for HPV Related Oropharyngeal Cancers with High Risk Features
por: Su, William, et al.
Publicado: (2016)

Advances in the Management of HPV-Related Oropharyngeal Cancer
por: De Felice, F., et al.
Publicado: (2019)

Sialendoscopy – a diagnostic and therapeutic approach subjectively rated by patients
por: Kopeć, Tomasz, et al.
Publicado: (2014)

Outcome after supracricoid laryngectomies in the material of ENT Department, Poznan University of Medical Sciences
por: Szyfter, Witold, et al.
Publicado: (2011)

De-intensification strategies in HPV-related oropharyngeal squamous cell carcinoma—a narrative review
por: Strohl, Madeleine P., et al.
Publicado: (2020)

Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma
por: Rybarczyk-Kasiuchnicz, Agnieszka, et al.
Publicado: (2021)

HPV vaccination disparities and strategies to prevent oropharyngeal cancer in males
por: Daniel, Casey L., et al.
Publicado: (2021)

Evaluation of p16(INK4a) expression as a single marker to select patients with HPV-driven oropharyngeal cancers for treatment de-escalation
por: Wagner, Steffen, et al.
Publicado: (2020)

Fertility Counseling in BRCA1/2-Mutated Women with Breast Cancer and Healthy Individuals
por: Kufel-Grabowska, Joanna, et al.
Publicado: (2022)

Concurrent cisplatin or cetuximab with radiotherapy for HPV-positive oropharyngeal cancer: Medical resource use, costs, and quality-adjusted survival from the De-ESCALaTE HPV trial
por: Jones, David A., et al.
Publicado: (2020)

Sialoendoscopy and combined approach for the management of salivary gland stones
por: Kopeć, Tomasz, et al.
Publicado: (2012)

Impact of HPV in Oropharyngeal Cancer
por: Marklund, Linda, et al.
Publicado: (2011)

De-Escalating Strategies in HPV-Associated Head and Neck Squamous Cell Carcinoma
por: Economopoulou, Panagiota, et al.
Publicado: (2021)

De-Escalation Strategies for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma—Where Are We Now?
por: Silver, Jennifer A., et al.
Publicado: (2022)

Correction: Evaluation of p16(INK4a) expression as a single marker to select patients with HPV-driven oropharyngeal cancers for treatment de-escalation
por: Wagner, Steffen, et al.
Publicado: (2021)

Parental perceptions of the HPV vaccine for prevention of anogenital and oropharyngeal cancers
por: Schwartz, Beth I., et al.
Publicado: (2023)

Attempt to improve functional outcomes in supracricoid laryngectomy in T2b and T3 glottic cancers
por: Leszczyńska, Małgorzata, et al.
Publicado: (2014)

Stem cell treatments for oropharyngeal dysphagia: Rationale, benefits, and challenges
por: Tran, Eric K, et al.
Publicado: (2020)

Therapeutic Vaccines for HPV-Associated Oropharyngeal and Cervical Cancer: The Next De-Intensification Strategy?
por: Morand, Grégoire B., et al.
Publicado: (2022)

Low Prevalence of HPV Related Oropharyngeal Carcinogenesis in Northern Sardinia
por: Bussu, Francesco, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_grms2p89415hjqd014b8qr2fu6